PMA device
Surpass Elite Flow Diverter System
Stryker Neurovascular · Intracranial Aneurysm Flow Diverter (OUT, Class III) · First FDA decision May 18, 2024, newest May 18, 2024Brain aneurysm
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
1
Naming "Surpass Elite"
MAUDE reports
72
Brand "Surpass Elite", since 2015
PubMed studies
9
Mentioning "Surpass Elite"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Surpass Elite Flow Diverter System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Surpass Elite Flow Diverter SystemPMA supplement
P170024-S012 · Decided May 18, 2024 · 383 days after receipt · Normal 180 Day Track
Device type: Intracranial aneurysm flow diverter (OUT) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Surpass Elite", any status and sponsor, newest update first.
Stryker NeurovascularPublic (SYK)
NCT06872684 · 183 participants (planned) · Start Jun 20, 2025 · Primary completion Jan 31, 2029
Device: Surpass Elite with Guardian Flow Diverter System · For: Aneurysm; Aneurysm, Intracranial
Sites: Tucson, Arizona; Davis, California; Los Angeles, California · 20 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Surpass Elite", and for the whole product code for context.
This brand
72 reports: 40 malfunction, 31 injury, 1 death
Whole product code OUT
10,961 reports: 7,308 malfunction, 3,152 injury, 499 death
Newest reports for this brand
- SURPASS ELITE FDS 3.75MM X 12MM - PMASMalfunction
3008881809-2026-00650 · Received Oct 28, 2026 · Event dated Oct 9, 2026
Device type: Intracranial Aneurysm Flow Diverter (OUT)
Device problem as coded: Migration
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SURPASS ELITE FDS 3.25MM X 15MM - CEMalfunction
3008881809-2026-00642 · Received Oct 20, 2026 · Event dated Oct 13, 2026
Device type: Intracranial Aneurysm Flow Diverter (OUT)
Device problem as coded: Premature Activation
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SURPASS ELITE FDS 3.25MM X 20MM - PMASMalfunction
3008881809-2026-00580 · Received Sep 17, 2026 · Event dated Feb 25, 2026
Device type: Intracranial Aneurysm Flow Diverter (OUT)
Device problem as coded: Deformation Due to Compressive Stress
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Surpass Elite"[tiab]. The summary above synthesizes these.
- Thrombus Deposition on Surface Modified Flow Diverting Stents in A Novel Bifurcation Blood Flow Loop Model.
Srinivasan VM, Marley AM, Brochu AB, et al. · AJNR Am J Neuroradiol · 2026
- Assessing braid morphology after surpass elite flow diversion.
Ustundag A, Bagcilar O · Neuroradiology · 2026Letter
- Computational flow dynamics of a novel next-generation flow diverter.
Patrick MM, Santhanaraman S, Raja J, et al. · J Neurointerv Surg · 2026
- DWI-based comparison of thrombogenicity between Surpass Evolve and Surpass Elite flow diverters: an IPTW-adjusted study.
Kim KU, Kim JJ, Park KY, et al. · AJNR Am J Neuroradiol · 2026
- Early experience with the Surpass Elite flow diverter for unruptured intracranial aneurysms.
Ajem M, Kalsoum E, Farhat F, et al. · Neuroradiology · 2026
- First clinical experience with the surpass elite flow diverter in the treatment of intracranial aneurysms.
Gandhi OH, Almasri S, Ahmed W, et al. · Neuroradiology · 2026Multicenter Study
- A Novel Hybrid Endovascular Technique for Tympanojugular Paraganglioma: Flow Diversion Followed by Direct Transauricular Squid Embolization.
Fairhead R, Obholzer R, Patankar T, et al. · Neurointervention · 2026Case Reports
- Thrombogenicity assessment of surface-modified flow diverters: the impact of different surface modification strategies on thrombin generation in an acute in vitro test.
Charbonnier G, Cancelliere NM, Brochu AB, et al. · J Neurointerv Surg · 2026
- Endoluminal Reconstruction of Complex Cervical Internal Carotid Artery Dissections Using the Surpass Elite Flow Diverter: A Technical Report.
García H, Ahumada F, Diaz O · Cureus · 2026
Other devices of this type
Also filed under product code OUT.
- Pipeline Flex Embolization Device with Shield TechnologyMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · PMA 2021
- Flow Re-Direction Endoluminal Device (FRED®) SystemMicroVention, Inc. · PMA 2025
- Pipeline Embolization Devices,pipeline Flex Embolization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · PMA 2015
- Pipeline Vantage Embolization Device with Shield TechnologyMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · PMA 2025
- Surpass Streamline Flow DiverterStryker Neurovascular · PMA 2022
- FRED X SystemMicroVention, Inc. · PMA 2022
- Surpass Evolve Flow Diverter SystemStryker Neurovascular · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.